Zimmer Partners’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-15,889
Closed -$596K 137
2020
Q2
$596K Buy
+15,889
New +$596K 0.01% 94